The Society of Clinical Research and Medical Professionals (SCRMP) is set to host its prestigious Annual International Conference 2025 on August 23, 2025, at Medicaps University, Indore, Madhya Pradesh.
With the theme “The Future of Drug Safety: From Clinical Trials to Real-World Evidence,” the event promises to be a landmark gathering of global leaders in pharmacovigilance, regulatory science, clinical research; Academician’s and students.
The conference will feature participation from over 14 international organizations, including IQVIA, Syneos Health, Bristol Myers Squibb (BMS), Freyr Solutions, Novartis, and Clinxel, reinforcing SCRMP’s role as a dynamic platform for industry-academia collaboration and policy dialogue in life sciences.
Key figures leading the event include Gurpreet Singh, Vice President at IQVIA (UK) and President of SCRMP; DrTarunjot Singh, Director at Syneos Health (UK) and Vice President of SCRMP; and Mohammad Gayoor Khan, Co-Founder & General Secretary of SCRMP. These leaders, alongside Dr. Umama Yezdani, Founder of SCRMP, envision the conference as a platform to bridge academia and real-world industry practice, empowering young professionals and driving regulatory innovation.
“This conference will offer students and professionals an immersive experience into real-world pharmacovigilance, post-marketing surveillance, and international regulatory practices,” said Gurpreet Singh. “We are committed to creating global exposure and aligning India’s clinical research capabilities with global standards.”
Tarunjot Singh added, “The collaboration between SCRMP, Medicaps University, and global stakeholders is a transformative initiative that will set new benchmarks in academic-industry engagement. Our goal is to equip the next generation with actionable insights and applied knowledge.”
Mohammad Gayoor khan added This conference will bring together industry leaders, academicians, and students on a single platform, aligning with the core mission of the Society of Clinical Research and Medical Professionals (SCRMP).We are also offering conference proceedings and hosting a range of engaging activities such as poster presentations , Annual SCRMP Magzine and expert-led sessions.
This event aims to broaden perspectives and provide valuable insights into the current landscape of clinical research and the pharmacovigilance (PV) industry.
Pannelist Industry experts joining such as Punam Kumari , Dr Shipra Sehgal, Dr Rohni Pandey, Gurpreet Kaur,Dr. Himanshu Bhatnagar, Dr Harsimran Kaur, Nishth Vyas, Priya Vyas , Nikhil C Bhanumati, Dr Siva Kumar Buddha offering global perspectives on drug safety, public health, and regulatory strategy.
Academic Publishing Milestone
In a major academic initiative, SCRMP will officially launch the first issue of the “Journal of Patient Safety & Epidemiology”, a peer-reviewed publication focusing on pharmacovigilance, health outcomes, and public health surveillance.
Additionally, in collaboration with Medicaps University and SCRMP publishing division EndricScience, SCRMP will unveil a new interdisciplinary journal dedicated to pharmacy, clinical research, and drug development. This journal aim to provide an accessible publishing platform for students, early-career researchers, and healthcare professionals committed to evidence-based practices.
Academic Leadership
Medicaps University is playing a central role in hosting the conference, with Dr Sanjay Jain (Principal, College of Pharmacy at Medicaps University as Conference Chairman, Dr Hemant Khambete as Convenor, and Prof. Ritu Sapra as Organising Secretary. Their leadership, combined with support from SCRMP’s Faculty Forum, underlines the institution’s commitment to research-driven education.
The Annual SCRMP International Conference 2025 is expected to attract hundreds of delegates from across India and abroad, making it one of the most anticipated events in the clinical research and pharmacovigilance calendar.
